Ventaris Surgical, Inc. secures $30M in Series A funding led by Longitude Capital to enhance kidney stone treatment technology.
Amount Raised
$30 Million
Round Type
Series A
San CarlosBiotechnologyHealth CareMedicalInvestors
Description
Ventaris Surgical, Inc. has completed a $30 million Series A financing round to advance its next-generation kidney stone treatment system. The round was led by Longitude Capital, with additional contributions from Vensana Capital and several existing investors. Ventaris aims to improve procedural outcomes and reduce surgeon burden through innovative technology
Quick answer
Ventaris Surgical raised $30 Million in a Series A round, dated January 9, 2026. Investors: Vensana Capital, Atypical Ventures, Neotribe Ventures, Boutique Venture Partners and Longitude Capital. Ventaris Surgical is based in San Carlos, California, United States.
- How much did Ventaris Surgical raise?
- Ventaris Surgical raised $30 Million in a Series A round on January 9, 2026.
- Who invested in Ventaris Surgical?
- Vensana Capital, Atypical Ventures, Neotribe Ventures, Boutique Venture Partners and Longitude Capital are named as investors in this round.
- What does Ventaris Surgical do?
- Ventaris Surgical, Inc. is a privately held medical device company developing a novel ureteroscopic system to help surgeons achieve more complete stone clearance in kidney stone procedures.
- Where is Ventaris Surgical based and how big is it?
- Ventaris Surgical is based in San Carlos, California, United States. Fundz records about 8 employees.
- Who are the decision-makers at Ventaris Surgical?
- Fundz holds 1 contact at Ventaris Surgical. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Biotechnology around the same time
Companies in the same sectors as Ventaris Surgical that raised within 45 days of this round, from Fundz verified event records.
- Oncare raised $3M (Series A) on February 23, 2026.
- Faeth Therapeutics raised $200M (Post-IPO Equity) on February 18, 2026.
- Nihin Media raised an undisclosed amount (Funding Round) on February 18, 2026.
- ClotProtect raised $1.6M (Seed) on February 18, 2026.
- Elumn8 Medical raised an undisclosed amount (Series C) on February 18, 2026.
- Matresa raised $428K (Pre-Seed) on February 17, 2026.
Who to call at Ventaris Surgical, and when
A new round usually means Ventaris Surgical is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ventaris Surgical raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ventaris Surgical, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ventaris Surgical. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ventaris Surgical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansVentaris Surgical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.